Role of Src in vascular hyperpermeability induced by advanced glycation end products

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhang, Weijin ^a   Xu, Qiulin ^b,c   Wu, Jie ^a   Zhou, Xiaoyan ^a   Weng, Jie ^a   Xu, Jing ^a   Wang, Weiju ^a   Huang, Qiaobing ^a   Guo, Xiaohua ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^c Postdoctoral Workstation Huabo Bio pharmaceutical Research Institute ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CADHERIN; LEUKOCYTE ANTIGEN; MOESIN; PROTEIN TYROSINE KINASE; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL; CAPILLARY PERMEABILITY; CELL CULTURE; DRUG EFFECTS; ENDOTHELIUM CELL; GENE INACTIVATION; GENETICS; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ACTINS; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; ANTIGENS, CD; CADHERINS; CAPILLARY PERMEABILITY; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE KNOCKOUT TECHNIQUES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84941922766     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14090     Document Type: Article

References (50)

1. Manigrasso, M. B., Juranek, J., Ramasamy, R. & Schmidt, A. M. Unlocking the biology of RAGE in diabetic microvascular complications. Trends Endocrinol Metab 25, 15-22 (2014).
2. Basta, G., Schmidt, A. M. & De Caterina, R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63, 582-592 (2004).
3. Mulder, D. J. et al. Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus. Atherosclerosis 218, 102-106 (2011).
4. Sena, C. M. et al. Methylglyoxal promotes oxidative stress and endothelial dysfunction. Pharmacol Res 65, 497-506 (2012).
5. Vlassara, H. Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues. Diabetes 41 Suppl 2, 52-56 (1992).
6. Bonnardel-Phu, E., Wautier, J. L., Schmidt, A. M., Avila, C. & Vicaut, E. Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes 48, 2052-2058 (1999).
7. Guo, X. et al. ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability. Am J Physiol Heart Circ Physiol 297, H238-246 (2009).
8. Bolton, W. K. et al. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol 24, 32-40 (2004).
9. Kim, M. P., Park, S. I., Kopetz, S. & Gallick, G. E. Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis. Cell Tissue Res 335, 249-259 (2009).
10. Hu, G., Place, A. T. & Minshall, R. D. Regulation of endothelial permeability by Src kinase signaling: vascular leakage versus transcellular transport of drugs and macromolecules. Chem Biol Interact 171, 177-189 (2008).
11. Lehr, H. A., Bittinger, F. & Kirkpatrick, C. J. Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy? J Pathol 190, 373-386 (2000).
12. Nathan, C. Points of control in inflammation. Nature 420, 846-852 (2002).
13. Yuan, Y., Huang, Q. & Wu, H. M. Myosin light chain phosphorylation: modulation of basal and agonist-stimulated venular permeability. Am J Physiol 272, H1437-1443 (1997).
14. Han, J. et al. A critical role for Lyn kinase in strengthening endothelial integrity and barrier function. Blood 122, 4140-4149 (2013).
15. Tinsley, J. H., Ustinova, E. E., Xu, W. & Yuan, S. Y. Src-dependent, neutrophil-mediated vascular hyperpermeability and betacatenin modification. Am J Physiol Cell Physiol 283, C1745-1751 (2002).
16. Adam, A. P., Sharenko, A. L., Pumiglia, K. & Vincent, P. A. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. J Biol Chem 285, 7045-7055 (2010).
17. Orsenigo, F. et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 3, 1208 (2012).
18. Luo, P. et al. Advanced glycation end products induce glomerular endothelial cell hyperpermeability by upregulating matrix metalloproteinase activity. Mol Med Rep 11, 4447-4453 (2015).
19. Wu, X. D. et al. Advanced glycation end products activate the miRNA/RhoA/ROCK2 pathway in endothelial cells. Microcirculation 21, 178-186 (2014).
20. Niiya, Y., Abumiya, T., Yamagishi, S., Takino, J. & Takeuchi, M. Advanced glycation end products increase permeability of brain microvascular endothelial cells through reactive oxygen species-induced vascular endothelial growth factor expression. J Stroke Cerebrovasc Dis 21, 293-298 (2012).
21. Sheikpranbabu, S., Haribalaganesh, R., Lee, K. J. & Gurunathan, S. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability. Biochimie 92, 1040-1051 (2010).
22. Navaratna, D., McGuire, P. G., Menicucci, G. & Das, A. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 56, 2380-2387 (2007).
23. Yamagishi, S. et al. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem 281, 20213-20220 (2006).
24. Goldin, A., Beckman, J. A., Schmidt, A. M. & Creager, M. A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114, 597-605 (2006).
25. Campbell, E. J. et al. Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer. Br J Cancer 99, 1769-1774 (2008).
26. Reddy, M. A. et al. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem 281, 13685-13693 (2006).
27. Cassese, A. et al. In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. J Biol Chem 283, 36088-36099 (2008).
28. Brizzi, M. F. et al. STAT5 activation induced by diabetic LDL depends on LDL glycation and occurs via src kinase activity. Diabetes 51, 3311-3317 (2002).
29. Toure, F. et al. Formin mDia1 mediates vascular remodeling via integration of oxidative and signal transduction pathways. Circ Res 110, 1279-1293 (2012).
30. Berryman, M., Franck, Z. & Bretscher, A. Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 105 (Pt 4), 1025-1043 (1993).
31. Koss, M. et al. Ezrin/radixin/moesin proteins are phosphorylated by TNF-alpha and modulate permeability increases in human pulmonary microvascular endothelial cells. J Immunol 176, 1218-1227 (2006).
32. Neisch, A. L. & Fehon, R. G. Ezrin, Radixin and Moesin: key regulators of membrane-cortex interactions and signaling. Curr Opin Cell Biol 23, 377-382 (2011).
33. Niggli, V. & Rossy, J. Ezrin/radixin/moesin: versatile controllers of signaling molecules and of the cortical cytoskeleton. Int J Biochem Cell Biol 40, 344-349 (2008).
34. Wang, L. et al. Advanced glycation end products induce moesin phosphorylation in murine retinal endothelium. Acta Diabetol 49, 47-55 (2012).
35. Wang, J. et al. RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response. Cardiovasc Diabetol 11, 7 (2012).
36. Dejana, E., Orsenigo, F. & Lampugnani, M. G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121, 2115-2122 (2008).
37. Gavard, J. Endothelial permeability and VE-cadherin: a wacky comradeship. Cell Adh Migr 8, 158-164 (2014).
38. Gavard, J. & Gutkind, J. S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8, 1223-1234 (2006).
39. Spring, K. et al. Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation. Blood 120, 2745-2756 (2012).
40. Calalb, M. B., Polte, T. R. & Hanks, S. K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 15, 954-963 (1995).
41. Laird, A. D. et al. Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells. Mol Cancer Ther 2, 461-469 (2003).
42. Eliceiri, B. P. et al. Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol 157, 149-160 (2002).
43. Quadri, S. K. & Bhattacharya, J. Resealing of endothelial junctions by focal adhesion kinase. Am J Physiol Lung Cell Mol Physiol 292, L334-342 (2007).
44. Belvitch, P. & Dudek, S. M. Role of FAK in S1P-regulated endothelial permeability. Microvasc Res 83, 22-30 (2012).
45. Mehta, D. et al. Modulatory role of focal adhesion kinase in regulating human pulmonary arterial endothelial barrier function. J Physiol 539, 779-789 (2002).
46. Chen, X. L. et al. VEGF-induced vascular permeability is mediated by FAK. Dev Cell 22, 146-157 (2012).
47. Zhao, X., Peng, X., Sun, S., Park, A. Y. & Guan, J. L. Role of kinase-independent and -dependent functions of FAK in endothelial cell survival and barrier function during embryonic development. J Cell Biol 189, 955-965 (2010).
48. Hu, G., Vogel, S. M., Schwartz, D. E., Malik, A. B. & Minshall, R. D. Intercellular adhesion molecule-1-dependent neutrophil adhesion to endothelial cells induces caveolae-mediated pulmonary vascular hyperpermeability. Circ Res 102, e120-131 (2008).
49. Xu, Q. et al. Heat Stress-Induced Disruption of Endothelial Barrier Function Is via PAR1 Signaling and Suppressed by Xuebijing Injection. PLoS One 10, e0118057 (2015).
50. Hou, F. F. et al. beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney Int 59, 990-1002 (2001).